PRISM Mid-Day Movers: Biotech Breakthroughs and Ethereum Exposure Fuel Gains

2025-07-08 14:00:35 ET

ZyVersa Therapeutics Surges 126% on FDA Compassionate Use for Ultra-Rare Kidney Disease
ZyVersa Therapeutics, Inc. ( ZVSA ) soared 125.67% to lead the PRISM Emerging Biotech Index after the FDA approved emergency compassionate use of its investigational kidney disease drug, VAR 200, for a patient with ultra-rare ApoCII amyloidosis. The decision was based on preclinical data suggesting VAR 200's potential to prevent lipid buildup and kidney damage, providing hope in a condition with no approved therapies.

The rally was further fueled by news of a $2.0 million warrant inducement agreement with an institutional investor . The deal provides immediate working capital as ZyVersa continues advancing its renal and inflammatory disease pipeline. In return for exercising existing warrants at a reduced price, the investor received new unregistered Series A-4 warrants, set to be exercisable following shareholder approval. The move reflects growing confidence in ZyVersa's platform and a strategic step to strengthen its financial footing.

SharpLink Rallies on Expanded Ethereum Holdings and Staking Rewards
SharpLink Gaming, Inc. ( SBET ) climbed 18.82% in the PRISM Emerging Sports Index after revealing it has grown its Ethereum holdings to 205,634 ETH , making it the largest publicly traded company using ETH as its primary treasury reserve. The company earned 322 ETH in staking rewards since launching its crypto treasury strategy on June 2 and introduced a new "ETH Concentration" metric to enhance investor transparency. SharpLink raised $64 million last week and plans to deploy another $37.2 million in ETH purchases, signaling further expansion of its digital asset strategy.

Other PRISM Mid-Day Movers:
? Moleculin Biotech, Inc. ( MBRX ) up 30.04%
? ABVC BioPharma, Inc. ( ABVC ) up 29.05%
? Soluna Holdings, Inc. ( SLNH ) up 16.55%
? Humacyte, Inc. ( HUMA ) up 19.91%

The post PRISM Mid-Day Movers: Biotech Breakthroughs and Ethereum Exposure Fuel Gains appeared first on PRISM MarketView .

COMTEX_467112751/2927/2025-07-08T13:00:35